Aimei Health Ownership
AFJK Stock | 11.00 0.01 0.09% |
Aimei |
Aimei Stock Ownership Analysis
About 34.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. For more info on Aimei Health Technology please contact Junheng Xie at 212 845 9945.Aimei Health Technology Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aimei Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aimei Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aimei Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mizuho Securities Usa Llc over a month ago Disposition of 150000 shares by Mizuho Securities Usa Llc of Aimei Health at 10.86 subject to Rule 16b-3 | ||
Mizuho Securities Usa Llc over a month ago Insider Trading | ||
Karlsen Robin H over a year ago AIMEI HEALTH exotic insider transaction detected |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aimei Health Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aimei Health. If investors know Aimei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aimei Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aimei Health Technology is measured differently than its book value, which is the value of Aimei that is recorded on the company's balance sheet. Investors also form their own opinion of Aimei Health's value that differs from its market value or its book value, called intrinsic value, which is Aimei Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aimei Health's market value can be influenced by many factors that don't directly affect Aimei Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aimei Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aimei Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aimei Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.